Aspen-01: A Phase 1 Study Of Alx148, A Cd47 Blocker, In Combination With Trastuzumab, Ramucirumab And Paclitaxel In Patients With Second-Line Her2-Positive Advanced Gastric Or Gastroesophageal Junction Cancer

H. Chung,K. Lee, W. Kim, J. Gainor,N. Lakhani, L. Chow,W. Messersmith, P. Fanning,P. Squifflet, F. Jin, A. Forgie, H. Wan, J. Pons, S. Randolph,P. Lorusso

ANNALS OF ONCOLOGY(2021)

引用 5|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要